Yüklüyor......
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury
Acute kidney disease (AKI) leads to increased risk of progression to chronic kidney disease (CKD). Antithrombin III (ATIII) is a potent anticoagulant with anti‐inflammatory properties, and we previously reported that insufficiencies of ATIII exacerbated renal ischaemia‐reperfusion injury (IRI) in ra...
Kaydedildi:
| Yayımlandı: | J Cell Mol Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5706518/ https://ncbi.nlm.nih.gov/pubmed/28767184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13261 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|